Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Susan L Samson, MD PhD
Pituitary Center at Baylor St. Luke's Medical
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
60 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St Vincent'S Private Hospital-Nsw
Darlinghurst, New South Wales, Australia
- Royal North Shore Public Hospital
St Leonards, New South Wales, Australia
- St Vincent'S Hospital-Vic
Fitzroy, Victoria, Australia
- the Alfred
Melbourne, Victoria, Australia
- Melbourne Health
Parkville, Victoria, Australia
- Keogh Institute (sir Charles Gardner)
Nedlands, Western Australia, Australia
- University Specialized Hospital for Active Treatment of Endocrinology "acad. Iv. Pencev" Ead
Sofia, Bulgaria
- University of British Columbia
Vancouver, British Columbia, Canada
- St Joseph'S Health Care
London, Ontario, Canada
- Mcgill University Health Centre
Montreal, Quebec, Canada
- Aarhus University Hospital
Aarhus, Denmark
- Rigshospitalet the Department of Endocrinology
Copenhagen, Denmark
- Rwth Aachen University Hospital, Medical Clinic Iii Division of Endocrinology and Diabetes
Aachen, Germany
- Klinikum Der Lmu Muenchen, Medizinische Klinik Und Poliklinik Iv, Endokrinologie
Munich, Germany
- Magyar Honvedseg Egeszsegugyi Kozpont, Ii. Sz. Belgyogyaszati Osztaly
Budapest, Hungary
- University of Semmelweiss, Budapest
Budapest, Hungary
- Szegedi Tudományegyetem, I. Belgyógyászati Klinika
Szeged, Hungary
- Hadassah Ein-Karem Medical Center
Jerusalem, Israel
- Rabin Medical Center, Beilinson Hospital
Petah Tikva, Israel
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
- Policlinico Di Monserrato U.O.C. Endocrinologia E Diabetologia
Monserrato, Italy
- Azienda Ospedaliero-Universitaria Pisana, Università Di Pisa
Pisa, Italy
- Riga Eastern Clinical University, Hospital Gailezers Department of Endocrinology
Riga, Latvia
- Leids Universitair Medisch Centrum
Leiden, Netherlands
- Erasmus Medisch Centrum
Rotterdam, Netherlands
- Dunedin Hospital
Dunedin, New Zealand
- Wellington Hospital
Wellington, New Zealand
- Katedra I Klinika Endokrynologii I Chorob Wewnetrznych
Gdansk, Poland
- Uniwersyteckie Centrum Okulistyki I Onkologii Samodzielny Publiczny Szpital Kliniczny Slaskiego Uniwersytetu Medycznego W Katowicach, Oddzial Endokrynologii
Katowice, Poland
- Szpital Uniwersytecki W Krakowie, Oddzial Kliniczny Endokrynologii
Krakow, Poland
- Klinika Chorob Wewnetrznych I Endokrynologii
Warsaw, Poland
- Samodzielny Publiczny Szpital Kliniczny Nr 1 We Wroclawiu, Klinika Endokrynologii, Diabetologii I Leczenia Izotopami
Wroclaw, Poland
- Medical University Centre Ljubljana
Ljubljana, Slovenia
- Sahlgrenska University Hospital
Gothenburg, Sweden
- Ankara University, Faculty of Medicine
Ankara, Turkey (Türkiye)
- Hacettepe University Medical School
Ankara, Turkey (Türkiye)
- Ege University Medical Faculty Internal Diseases
Izmir, Turkey (Türkiye)
- Erciyes University Medical Faculty
Kayseri, Turkey (Türkiye)
- University Hospitals Birmingham Nhs Foundation Trust, Queen Elizabeth Hospital
Birmingham, United Kingdom
- Central Manchester University Hospitals Nhs Foundation Trust, Manchester Royal Infirmary
Manchester, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Sept 2017
- Primary completion
- 13 Jun 2019
- Completion
- 31 May 2022
- Last update posted
- 23 Nov 2020
- Registered enrollment
- 56
- Registry id
- NCT03252353
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.